Effects of SNF472, a Novel Inhibitor of Hydroxyapatite Crystallization in Patients Receiving Hemodialysis — Subgroup Analyses of the CALIPSO Trial
Titel:
Effects of SNF472, a Novel Inhibitor of Hydroxyapatite Crystallization in Patients Receiving Hemodialysis — Subgroup Analyses of the CALIPSO Trial
Auteur:
Raggi, Paolo Bellasi, Antonio Sinha, Smeeta Bover, Jordi Rodriguez, Mariano Ketteler, Markus Bushinsky, David A. Garg, Rekha Perelló, Joan Gold, Alex Chertow, Glenn M.